Last reviewed · How we verify
Vitamin B12, B9, B6, C supplementation — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Vitamin B12, B9, B6, C supplementation (Vitamin B12, B9, B6, C supplementation) — Assistance Publique - Hôpitaux de Paris.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Vitamin B12, B9, B6, C supplementation TARGET | Vitamin B12, B9, B6, C supplementation | Assistance Publique - Hôpitaux de Paris | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Vitamin B12, B9, B6, C supplementation CI watch — RSS
- Vitamin B12, B9, B6, C supplementation CI watch — Atom
- Vitamin B12, B9, B6, C supplementation CI watch — JSON
- Vitamin B12, B9, B6, C supplementation alone — RSS
Cite this brief
Drug Landscape (2026). Vitamin B12, B9, B6, C supplementation — Competitive Intelligence Brief. https://druglandscape.com/ci/vitamin-b12-b9-b6-c-supplementation. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab